Michael L. Lipton

https://assets.montefioreeinstein.org/profiles/images/Lipton_Michael_MD_420x504.jpg

First Name

Michael

Last Name

Lipton

NPI

1366535502

Faculty ID

148

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><strong>Michael L. Lipton, M.D., Ph.D., F.A.C.R.</strong><br />Dr. Lipton, a neuroradiologist and neuroscientist, is Associate Director of the Gruss Magnetic Resonance Research Center at Einstein and &nbsp;Medical Director of MRI Services for Montefiore Health, both in New York. He divides his professional time between the clinical practice of neuroradiology, teaching and research. Dr. Lipton&rsquo;s research broadly addresses the use of advanced noninvasive imaging technology to reveal heretofore-inaccessible substrates of brain dysfunction, particularly in the realms of behavior and cognition. More specifically, his research program has focused for nearly a decade on detecting and characterizing the effects of mild brain injury (AKA concussion). Specific areas of emphasis at present include the understanding of inter-individual differences in the manifestations of brain injury and the cumulative effects of repetitive subconcussive injury in sports. Dr. Lipton&rsquo;s work on the impact of subconcussive &ldquo;heading&rdquo; on brain structure and function in amateur soccer players, funded by the Dana Foundation and the National Institutes of Health, has been reported extensively in the press worldwide.</p>

Research Areas

Research Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Dr. Lipton develops and applies advanced quantitative MRI to enhance characterization of brain disease in patients with persistent symptoms related to traumatic brain injury and other disorders that are not adequately visualized using conventional imaging approaches</p>

Research Focus

<p>Dr. Lipton applies advanced imaging technology to characterize the effects of trauma on behavior and cognition. His work on repeated subconcussive head impacts in soccer players has been reported extensively in the press worldwide.</p>

Elsevier Profile

Biography

<p>Michael L. Lipton, MD, PhD, FACR, is the Medical Director of MRI Services and an Attending Radiologist at Montefiore. He is also a Professor of Radiology, Psychiatry and Behavioral Sciences at our Albert Einstein College of Medicine. Dr. Lipton has been a member of the Montefiore team since 1997, with a clinical focus on developing advanced quantitative MRI to enhance characterization of brain diseases. He works primarily with patients who suffer persistent symptoms related to traumatic brain injury and other disorders that are not easily identified with conventional imaging approaches. </p><p>Dr. Lipton received his Doctor of Medicine from Boston University in 1990. He continued his studies by attending our Albert Einstein College of Medicine, where he received his Master of Science with Distinction and his Doctor of Philosophy in Neuroscience. His postgraduate training began with an internship in internal medicine at Brookdale Hospital Medical Center completed in 1991. Over 5 years, Dr. Lipton completed a residency and chief residency in diagnostic radiology, followed by a 2-year fellowship in neuroradiology at Montefiore, completing his postgraduate training in 1997. </p><p>Dr. Lipton has completed substantial research on repeated subconcussive head impacts in sports, particularly in soccer players. His work on this topic has been reported on extensively in the press worldwide. Dr. Lipton?s other research focuses mainly on the brain and has been shared in a number of presentations internationally, as well as published in numerous books and papers. </p><p>In 2017, Dr. Lipton received the Distinguished Investigator Award from the Academy of Radiology and Biomedical Imaging Research. Dr. Lipton is board certified by the American Board of Radiology, is a Fellow of the American College of Radiology and is a member of numerous professional societies, including the the American Medical Association, and the American Society of Neuroradiology. </p>

Is Open Scheduling

Off

Michael Yee

https://assets.montefioreeinstein.org/profiles/images/13771-michael-yee.jpg

First Name

Michael

Last Name

Yee

NPI

1699971085

Faculty ID

13771

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5456

Is Open Scheduling

Off

Daniel A. Weiser

https://assets.montefioreeinstein.org/profiles/images/Weiser_Daniel_MD_2x.jpg

First Name

Daniel

Last Name

Weiser

NPI

1225239700

Faculty ID

13846

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span style="text-decoration: underline;"><strong>Childhood cancer research laboratory</strong></span></p>
<p>Our laboratory is focused on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. In such patients with typically incurable cancer, we are striving to identify new approaches to and types of treatment. We have multiple ongoing projects:</p>
<p><strong>+ Identification of biologic drivers of ultra-high-risk neuroblastoma</strong>. Neuroblastoma is one of the most common and deadly childhood cancers. Despite intensive research, there are limited therapeutic strategies for patients with <em>de novo </em>chemotherapy resistance that leads to particularly poor outcomes. We have been studying neuroblastoma since 2009 and are identifying additional biologic drivers of highly lethal tumors.</p>
<p>We compare tumor features from patients with early death from tumor progression compared to those with a maintained complete response. We assess unique histo-morphologic and proteomic features and computationally integrate these data with genomic and transcriptomic datasets to develop a combined predictor of primary refractory disease. Patients with this entity require non-standard and/or intensified treatment. Oncogenic drivers are being characterized in the lab which will facilitate strategies for novel pharmacologic intervention.</p>
<p><strong>+ Characterization of neuroblastoma development from neural crest cells</strong>.&nbsp; We are studying pathways and interactions that results in uncontrolled cell proliferation early in neuroblastoma development with an ultimate goal of identifying new targets and approaches for pharmacologic intervention.</p>
<p><strong>+ Evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma</strong>.&nbsp; With expected outcomes lagging behind those of more common childhood cancers, children with neuroblastoma require new approaches to treatment. Our lab works with multiple international clinical and research consortium groups to perform preclinical studies that substantiate human clinical trials.&nbsp;</p>
<p><strong>+ Detection of circulating tumor DNA in osteosarcoma</strong>. With no reliable non-invasive approach for disease monitoring during and after treatment, we are applying cutting edge next-generation sequencing approaches to identify solid tumors with a blood-based &ldquo;liquid&rdquo; biopsies. This will allow clinicians to assess tumor responsiveness to chemotherapy and predict likelihood of recurrence.</p>
<p><strong>+ Assessment of accelerated aging using miRNA-seq in survivors of childhood cancer</strong>. Chemotherapy has many untoward effects on healthy cells and leads to many signs of accelerated aging in children treated for cancer. Using a known microRNA &ldquo;aging&rdquo; signature discovered at Albert Einstein College of Medicine, we are studying what causes this phenotype in childhood cancer, with a goal of offering improved intervention to minimize long-term toxicity of treatment.</p>
<p><strong><span style="text-decoration: underline;">Physician Summary</span></strong></p>
<p>Daniel A. Weiser, MD, is board-certified in pediatric hematology/oncology with clinical expertise in neuroblastoma and other tumors of the adrenal glands, kidneys, liver, and gonads. He is the medical director of the intra-abdominal solid tumor program at the Children&rsquo;s Hospital at Montefiore and brings together a highly specialized multi-disciplinary care team to provide comprehensive treatment for diverse pediatric malignancies. In addition, Dr. Weiser directs a childhood cancer research laboratory that focuses on the identification of new targeted agents for cancer therapy, especially in the treatment of rare and aggressive malignancies such as neuroblastoma. His research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise for improving management of all patients with solid tumors.</p>
<p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Advances in Neuroblastoma Research Association (ANRA), National Pediatric Cancer Foundation (NPCF), and the American Academy of Pediatrics (AAP). He has received numerous awards including the Brigid Leventhal Special Merit Award from ASCO and the Conquer Cancer Foundation, and a prestigious K12 from the National Cancer Institute for the training of the next generation of physician-scientists in pediatric cancer. Dr. Weiser is actively involved in teaching and mentorship of trainees, and takes great pride in providing advanced and compassionate care to his patients and their families.</p>
<p><strong>Clinical Expertise</strong></p>
<ul>
<li>Neuroblastoma (adrenal tumors)</li>
<li>Wilms tumor (renal tumors)</li>
<li>Hepatoblastoma (liver tumors)</li>
<li>Germ cell tumors (including testicular and ovarian tumors)</li>
<li>Thyroid and other rare tumors</li>
<li>Experimental therapeutics</li>
<li>Cancer genetics and biomarkers</li>
</ul>
<p><strong>Board Certifications</strong></p>
<ul>
<li>Pediatrics</li>
<li>Pediatric Hematology/Oncology</li>
</ul>
<p><strong>Professional Education</strong></p>
<ul>
<li>M.D. &ndash; Stony Brook University, NY</li>
<li>Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Chief Residency &ndash; Children&rsquo;s Hospital of NY-Presbyterian, Columbia University, NY</li>
<li>Fellowship &ndash; The Children&rsquo;s Hospital of Philadelphia, PA</li>
</ul>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

DR. Weiser's clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma, and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers.&nbsp;

Research Focus

Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others.

Elsevier Profile

EMR ID

5755

Biography

<p>Daniel A. Weiser, MD, is a Medical Director of the Intra-abdominal Solid Tumor Program in the Pediatrics Hematology/Oncology department at Children&rsquo;s Hospital at Montefiore. He is also Associate Professor in the Pediatrics and Genetics departments at the Albert Einstein College of Medicine. His clinical focuses are neuroblastoma and adrenal tumors, Wilms tumor and other kidney (renal) tumors, hepatoblastoma and other liver tumors, germ cell tumors (including testicular and ovarian tumors), Thyroid and other rare tumors, experimental therapeutics, and cancer genetics and biomarkers. Dr. Weiser is actively involved in teaching and mentorship of trainees and takes great pride in his active participation in patient care.</p><p>Dr. Weiser received his Bachelor of Science in Neurobiology in 1995 at Haverford College, PA. In 2004, he received his Doctor of Medicine at Stony Brook University School of Medicine, NY. He is currently earning his Master of Science in Translational Research at the University of Pennsylvania. He began a residency in Pediatrics at the New York-Presbyterian, Columbia University in 2007. Dr. Weiser then completed a three-year fellowship in Pediatric Hematology/Oncology at The Children&rsquo;s Hospital of Philadelphia. </p><p>Dr. Weiser&rsquo;s research goals are to understand the role of certain genes in the risk, development, and treatment of cancer. The approaches taken and agents studied hold promise in the treatment of all solid tumors. Dr. Weiser&rsquo;s laboratory focuses on childhood cancer research with a goal of elucidating the underlying biology of the most aggressive malignancies. He has multiple ongoing projects, such as identification of biologic drivers of neuroblastoma at ultra-high risk for treatment failure, characterization of neuroblastoma development from neural crest cells, and evaluation of novel combinatorial targeted therapeutic approaches in neuroblastoma, among others. His research has been published in many reviewed journals. </p><p>Dr. Weiser participates in the efforts of a number of professional organizations including the Children&rsquo;s Oncology Group (COG), American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), and the American Academy of Pediatrics (AAP). He has received many awards including the Brigid Leventhal Special Merit Award through ASCO, and he has been awarded a prestigious K12 from the NCI for the training of the next generation of physician-scientists in pediatric cancer.</p><p>He is board certified in Pediatric Hematology/Oncology and General Pediatrics.</p>

Is Open Scheduling

Off

Jacqueline Weingarten-Arams

https://assets.montefioreeinstein.org/profiles/images/physphoto/Weingarten_Jacqueline_MD_420x504.jpg

First Name

Jacqueline

Last Name

Weingarten-Arams

NPI

1558447409

Faculty ID

4831

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

Lab Website Link

EMR ID

3961

Biography

<p>Jacqueline Weingarten-Arams, MD, is an attending physician and Professor, Pediatrics at Montefiore Einstein. Dr. Weingarten-Arams&rsquo; pediatric critical care expertise focuses on cardiac critical care, acute hypoxemic respiratory failure, nutrition in critical illness and energy expenditure, cardiopulmonary resuscitation (quality CPR) and extracorporeal life support (ECMO).</p><p>After obtaining her Bachelor of Science in nutritional biochemistry at Cornell University in 1982, Dr. Weingarten-Arams earned her Doctor of Medicine at the same institution in 1986. She then completed her pediatric residency at Columbia University in 1990, where she was Chief Resident in her final year. Following this, Dr. Weingarten-Arams completed a fellowship in pediatric critical care medicine at New York Hospital Cornell University Medical College in 1996.</p><p>Dr. Weingarten-Arams research focus includes the use of deliberate simulated practice in improving outcomes in pediatric critical illness, pediatric resuscitation and pediatric airway management. Her other projects involve chronic critical illness, bioethics in pediatric critical care and oxidative injury in respiratory failure. She has been principal investigator and co-investigator on several research projects, and her work has been shared through numerous peer-reviewed publications and invited presentations.</p><p>Dr. Weingarten-Arams is a Diplomate of the National Board of Medical Examiners and the American Board of Pediatrics. She is a Fellow of the American Academy of Pediatrics and the American College of Chest Physicians. She is also a member of several professional organizations, including the American Medical Association, the Pediatric Cardiac Intensive Care Society and the Society of Critical Care Medicine. Dr. Weingarten-Arams has been named in Castle Connolly&rsquo;s &ldquo;Top Doctors: New York Metro Area&rdquo; for multiple years. In 2006, she was inducted into the Leo M. Davidoff Society and in 2019, Dr. Weingarten-Arams won the William Obrinsky Award for Excellence in Medical Student Education.</p>

Is Open Scheduling

Off

Henry Michael Ushay

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ushay_Michael_MD_420x504.jpg

First Name

Henry

Last Name

Ushay

NPI

1558332007

Faculty ID

10275

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric critical care medicine with a special emphasis on respiratory failure; shock resuscitation; cardiac intensive care; intensive care of pediatric oncology patients; extracorporeal support for children with respiratory and cardiovascular failure

Research Focus

Leadership and direction of the 16-bed Pediatric Critical Care Unit of The Children&rsquo;s Hospital at Montefiore; improving medication safety; respiratory physiology; advances in the management of respiratory failure in children; shock; medical ethics

Elsevier Profile

EMR ID

4763

Biography

<p>Dr. Ushay is Professor of Clinical Pediatrics in the Albert Einstein College of Medicine. He is a Fellow of the American Academy of Pediatrics as well as a Fellow of the American College of Critical Care Medicine. </p><p>After obtaining a PhD in Chemistry from Columbia University, Dr. Ushay received his MD from UMDNJ-New Jersey Medical School and completed a Pediatrics residency in the Montefiore-Jacobi-Einstein program. After serving as Chief Resident and a Fellow in Pediatric Pulmonology at Montefiore, he completed a Pediatric Critical Care Fellowship at New York Hospital/Cornell Medical Center in 1993. He was a faculty member at NewYork-Presbyterian and Memorial Sloan-Kettering Hospitals from 1993 to 2005, and he served as Pediatric Critical Care Medicine Fellowship Program Director and Medical Director of the Pediatric Observation Unit at Memorial Sloan-Kettering Cancer Center. </p><p>In 2005 Dr. Ushay became Director of the Pediatric Critical Care Unit in The Children&rsquo;s Hospital at Montefiore. Dr. Ushay is involved in increasing pediatric ICU surge capacity through the New York City Pediatric Disaster Coalition, serving on its Central Leadership Council and teaching the Pediatric Fundamental Critical Care Support Course. Through the National Institute of Child Health and Human Development, Dr. Ushay works on employing medical countermeasures safely for children in the event of chemical, biological or radiological disaster. Sponsored by Surgeons of Hope and Children&rsquo;s HeartLink, Dr. Ushay has worked as a cardiac intensivist in Cambodia, Africa, China and Nicaragua. </p>

Is Open Scheduling

Off

Marjan Rahmanian

https://assets.montefioreeinstein.org/profiles/images/physphoto/Rahmanian_Marjan_MD_420x504.jpg

First Name

Marjan

Last Name

Rahmanian

NPI

1033374434

Faculty ID

13978

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span>Dr. Marjan Rahmanian is an Assistant Professor of Medicine and Neurology. She is an Associate Medical Director of Cardiothoracic Intensive Care Unit at Montefiore Medical Center. She is also Medical Director of Physician Assistant Critical Care Residency program. She completed her Internal Medicine residency at Hackensack Meridian Mountainside Medical Center, followed by a fellowship in Critical Care Medicine at Mount Sinai Medical Center. After completing her training, she joined the faculty of the Albert Einstein College of Medicine in New York, where she served as an Associate Director of Cardiothoracic Surgical ICU at Montefiore Medical center. As a cardiac intensivist, Dr. Rahmanian focuses on the management of post heart surgery like CABG, valve replacemant, Mechanical Circulatory Support like,ECMO, LVAD,Impella, heart and lung transplant.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<ol>
<li>Maintaining Hemodynamic and Metabolic Homeostasis in Anheptaic Critically Ill Patients. Khan R, Go R, Kapoor S, Dharshan A, <strong>Marjan</strong> <strong>Rahmanian </strong>, Manasia A, Bassily-Marcus A, Kohli-Seth R, Oropello J, Benjamin E. CHEST. October 2012;142:390A-390A</li>
<li>The Heart Point Sign: An Ultrasonographic Confirmation Of Pneumothorax. R. Khan, M. <strong>Marjan</strong> <strong>Rahmanian</strong>, M. Kaufman, A. Bassily Marcus, J. Oropello. ajrccm-conference.2013.187.1 MeetingAbstracts.A1539</li>
<li>Cardiothoracic Surgical ICU Boot Camp can improve cardiovascular critical care knowledge among trainees. <strong>Marjan Rahmanian, </strong>MD; Lewis Eisen, MD; Adam Keene, MD; Rosemarie Conigliaro, MD; Anthony Carlese, DO ATS2018 Poster Presentation </li>
<li>Midodrine: Breaking New Ground in The Treament of Chylothorax: Dolly Patel, DO; <strong>Marjan Rahmanian, </strong>MD; Javed Iqbal, MD; Scott Scheinin, MD; Joshoua Lee, MD; Harish Seethamraju, MD Chest 2019 Poster Presentation</li>
<li>Lactate Dehydrogenase is Associated with Hemorrhagic Stroke During Extracorporeal Membrane Oxygenation for COVID-19 <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Saeed, O.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Uehara, M.</a>; <strong>Marjan</strong> <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank"><strong>Rahmanian</strong>.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Chen, J. T.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Carlese, A.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Mohamed, A.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Ashley, J.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Mellas, N.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Forest, S.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Goldstein, D.</a>; <a href="https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-201…; target="_blank">Jorde, U.</a>.<em>ASAIO Journal ; 68(Supplement 3):19, 2022.</em></li>
<li><a href="https://einstein.pure.elsevier.com/en/publications/hiv-dr-heartkidney-t…; target="_blank">HIV D+/R+ heart/kidney transplantation: First case report</a> <a href="https://einstein.pure.elsevier.com/en/persons/vagish-s-hemmige&quot; target="_blank">Hemmige, V.</a>, <a href="https://einstein.pure.elsevier.com/en/persons/omar-saeed&quot; target="_blank">Saeed, O.</a>, <a href="https://einstein.pure.elsevier.com/en/persons/yoram-a-puius&quot; target="_blank">Puius, Y. A.</a>, <a href="https://einstein.pure.elsevier.com/en/persons/yorg-al-azzi&quot; target="_blank">Azzi, Y.</a>, Colovai, A., Borgi, J., <a href="https://einstein.pure.elsevier.com/en/persons/daniel-j-goldstein&quot; target="_blank">Goldstein, D. J.</a>, Marjan Rahmanian, <a href="https://einstein.pure.elsevier.com/en/persons/anthony-j-carlese&quot; target="_blank">Carlese, A.</a>, <a href="https://einstein.pure.elsevier.com/en/persons/ulrich-p-jorde&quot; target="_blank">Jorde, U. P.</a> &amp; <a href="https://einstein.pure.elsevier.com/en/persons/snehal-r-patel&quot; target="_blank">Patel, S. R.</a>, Mar 2023, In: <a href="https://einstein.pure.elsevier.com/en/persons/anthony-j-carlese&quot; target="_blank">Journal of Heart and Lung Transplantation.</a> 42, 3, p. 406-408 3 p. </li>
<li>Chest Tube Insertion, Needle Thoracostomy, And Pericardiocentesis During In-hospital Cardiac Arrest <a title="Luke Andrea" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247&quot; target="_blank">Luke Andrea</a>, Marjan Rahmanian, <a title="Anthony Carlese" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247&quot; target="_blank">Anthony Carlese</a>, <a title="Ariel Shiloh" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247&quot; target="_blank">Ariel Shiloh</a>, <a title="Rithvik Balakrishnan" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247&quot; target="_blank">Rithvik Balakrishnan</a>, <a title="Aron Soleiman" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247&quot; target="_blank">Aron Soleiman</a>, <a title="Michelle Gong" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247&quot; target="_blank">Michelle Gong</a> and <a title="Ari Moskowitz" href="https://www.ahajournals.org/doi/10.1161/circ.146.suppl_1.247&quot; target="_blank">Ari Moskowitz</a> Circulation. 2022;146:A247</li>
</ol>

EMR ID

5749

Is Open Scheduling

Off

Deborah Orsi

https://assets.montefioreeinstein.org/profiles/images/13514-deborah-orsi.jpg

First Name

Deborah

Last Name

Orsi

NPI

1104025899

Faculty ID

13514

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5212

Is Open Scheduling

Off

Allison M. Martin

https://assets.montefioreeinstein.org/profiles/images/physphoto/Martin_Allison_MD_420x504.jpg

First Name

Allison

Last Name

Martin

NPI

1710200654

Faculty ID

15926

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

102070

Biography

<p>Allison M. Martin, MD, is an attending physician at the Children&rsquo;s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics, Microbiology and Immunology at our Albert Einstein College of Medicine. Dr. Martin&rsquo;s clinical focus centers on pediatric brain and spinal cord tumors.</p><p>After receiving her Bachelor of Arts in biology from Bryn Mawr College in 2001, Dr. Martin earned her Doctor of Medicine at Jefferson Medical College in 2007. She completed her pediatrics residency at the University of Pittsburgh in 2010, followed by a pediatric hematology/oncology fellowship at the Johns Hopkins University School of Medicine and the National Institutes of Health in 2013. Following this, Dr. Martin completed an additional fellowship in pediatric neuro-oncology at the Johns Hopkins University School of Medicine in 2014.</p><p>Dr. Martin&rsquo;s research focuses on high-risk group 3 and refractory medulloblastoma. Her research program focuses on uncovering new ways to harness the immune system to treat this disease. Her work has been shared through numerous peer-reviewed publications, abstracts, case reports and invited talks and panels. She has also been principal investigator and co-investigator on several funded research projects and is a reviewer for <em>Cancers</em>.</p><p>Dr. Martin is board certified in Pediatrics and Pediatric Hematology-Oncology. She is a member of the Children&rsquo;s Oncology Group (COG), the Cancer Therapy Evaluation Program (CTEP) and the Society of Immunotherapy and Cancer (SITC). In 2021, Dr. Martin received the Pediatric Hematology/Oncology Fellows Teaching Award from the Children&rsquo;s Hospital at Montefiore Einstein. She was named a &ldquo;Top Doctor&rdquo; by Castle Connolly in 2024.</p>

Is Open Scheduling

Off

Rishi Malhotra

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4e5ebe70-f4ea-11ed-b68f-a56b34798745.jpg

First Name

Rishi

Last Name

Malhotra

NPI

1154509933

Faculty ID

14085

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<span style="caret-color:#000000;font-family:Calibri, Arial, Helvetica, sans-serif;font-size:16px;text-size-adjust:auto;background-color:#ffffff;">Subarachnoid hemorrhage, Intracerebral Hemorrhage, Ischemic Stroke, Status Epilepticus, Neuromuscular Respiratory Failure, CNS Infections</span>

Research Focus

<span style="caret-color:#000000;font-family:Calibri, Arial, Helvetica, sans-serif;font-size:16px;text-size-adjust:auto;background-color:#ffffff;">Intracerebral Hemorrhage</span>

Elsevier Profile

EMR ID

5784

Biography

<p>Rishi Malhotra, MD, is Director of Neurocritical Care, Director of the Neuroscience ICU and Director of the Neurocritical Care Fellowship, as well as Associate Professor of Neurology, Medicine and Neurological Surgery at Montefiore Einstein. Dr. Malhotra&rsquo;s clinical focus includes the critical care management of subarachnoid hemorrhage, intracerebral hemorrhage, traumatic brain injury, acute spinal cord injury, ischemic stroke, status epilepticus, brain tumors, neuromuscular respiratory failure and central nervous system infections.</p><p>A graduate of the combined BA/MD program at Brooklyn College, Dr. Malhotra completed his Doctor of Medicine with State University of New York - Downstate Medical Center in 2004. After completing his internal medicine internship at St. Luke&rsquo;s-Roosevelt Hospital in 2005, Dr. Malhotra completed his three-year neurology residency at Columbia University Medical Center in 2008. He then pursued a neurocritical care fellowship at Columbia University Medical Center and Weill Cornell Medical Center, which he completed in 2010.</p><p>Dr. Malhotra&rsquo;s scholarly interests include intracerebral hemorrhage, hypoxic-ischemic brain injury and status epilepticus. He has shared his work through peer-reviewed journals, books, abstracts and poster presentations.</p><p>Dr. Malhotra is board certified in Neurology and Neurocritical Care. He is a member of the Neurocritical Care Society.</p>

Is Open Scheduling

Off

Sharon S. Leung

https://assets.montefioreeinstein.org/profiles/images/12323-sharon-leung.jpg

First Name

Sharon

Last Name

Leung

NPI

1639481328

Faculty ID

12323

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Dr. Leung graduated from SUNY Health Science Center at Brooklyn in 2005 and completed her internal medicine residency and critical-care medicine fellowship training at Monfefiore Medical Center. In 2009, house staff selected her as Fellow of the Year. In 2010, she was recruited to join the faculty and was supported by her division for the AECOM master&rsquo;s program in clinical research methods because of her interest in comparative effectiveness, cost, and outcome research. She further pursued her Executive MHA at Columbia Mailman School of Public Health, graduated in 2014.</span></p>
<p class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Dr. Leung became the associate director of critical care medicine for clinical operations and the medical director of the critical care physician assistant program in 2016. Her focus was to employ Lean Six Sigma methodology for process improvement, to evaluate the effectiveness of treatment strategies, to study health-care utilization and costs, and to evaluate physician compensation and productivity.</span></p>
<p class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">In 2019, Dr. Leung became the medical director for strategic initiatives for the medical center, managing the Triple Aim program and other operational projects. Seeing the bigger picture in health care and within the health system, she realized that relentless focus on value creation and delivery is the prerequisite of achieving the quadruple aim of health care. </span></p>
<p class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Dr. Leung was born in Hong Kong and moved to Bronx, New York, when she was 19.</span></p>
<p>&nbsp;</p>
<p class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Dr. Leung is board certified in:<br /></span></p>
<ul>
<li>
<div class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Internal Medicine<br /></span></div>
</li>
<li>
<div class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Critical Care Medicine<br /></span></div>
</li>
<li>
<div class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Hospice and Palliative Care Medicine</span></div>
</li>
<li>
<div class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Neurocritical Care Medicine&nbsp;<br /></span></div>
</li>
</ul>
<p class="MsoNoSpacing"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';">Research Interest:&nbsp;</span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif';"></span></p>
<ol start="1" type="1">
<li style="margin: 0in; color: black; font-style: normal; font-weight: normal; mso-list: l0 level1 lfo1; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list .5in;"><span style="font-family: 'Calibri',sans-serif; font-size: 11pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Health Policy and Management: Cost Effectiveness Analysis and Decision Making</span></li>
<li style="margin: 0in; color: black; font-style: normal; font-weight: normal; mso-list: l0 level1 lfo1; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list .5in;"><span style="font-family: 'Calibri',sans-serif; font-size: 11pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Value Management -- Quadruple Aim</span></li>
<li style="margin: 0in; color: black; font-style: normal; font-weight: normal; mso-list: l0 level1 lfo1; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list .5in;"><span style="font-family: 'Calibri',sans-serif; font-size: 11pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Time Driven Activity Based Costing</span></li>
</ol>
<p class="MsoNoSpacing">&nbsp;</p>
<p class="MsoNoSpacing">&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p>&nbsp;</p>
<ol style="list-style-type: decimal; direction: ltr;">
<li style="color: #000000; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Bodian D, <strong style="mso-bidi-font-weight: normal;">Leung S</strong>, Chiu H and Govind S.<span style="mso-spacerun: yes;">&nbsp; </span>Cytokines in Drosophila hematopoiesis and cellular immunity.<span style="mso-spacerun: yes;">&nbsp; </span>Prog Mol Subcell Biol. 2004;34:27-46.</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">, Storck K and LeFrancois D.<span style="mso-spacerun: yes;">&nbsp; </span>Visual Vignette: Subglottic Laryngeal Paraganglioma Presenting with Acute Airway Obstruction.<span style="mso-spacerun: yes;">&nbsp; </span>Endocr Pract. 2009 Mar-Apr;15(2):175.</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-bidi-font-weight: bold; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">,</span><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> Malhotra AD and LeFrancois D.<span style="mso-spacerun: yes;">&nbsp; </span>Not Just Another Case of Small Bowel Obstruction.<span style="mso-spacerun: yes;">&nbsp; </span></span><a><span style="color: windowtext; font-family: 'Calibri',sans-serif; font-size: 12pt; text-decoration: none; text-underline: none; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Clin Gastroenterol Hepatol.</span></a><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> 2009 Aug;7(8):A26. </span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-bidi-font-weight: bold; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">,</span><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> <span style="mso-bidi-font-weight: bold;">Metzger BS</span> and Currie BP.<span style="mso-spacerun: yes;">&nbsp; </span>Incidence of Clostridium difficile Infection in Acute Leukemia and Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation.<span style="mso-spacerun: yes;">&nbsp; </span></span><a title="Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America."><span style="color: windowtext; font-family: 'Calibri',sans-serif; font-size: 12pt; text-decoration: none; mso-bidi-font-style: italic; text-underline: none; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Infect Control Hosp Epidemiol.</span></a><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-bidi-font-style: italic; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"> 2010 Mar;31(3):313-5</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">, Malhotra AD and Eisen LA.<span style="mso-spacerun: yes;">&nbsp; </span>Venous Access Challenge on a Patient with Cerebral Palsy and Severe Kyphoscoliosis.<span style="mso-spacerun: yes;">&nbsp; </span><span style="mso-bidi-font-style: italic;">J Vasc Access. 2010 Jan-Mar;11(1):66-8.</span></span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Eisen LA, <strong style="mso-bidi-font-weight: normal;">Leung S</strong>, Gallagher AM and Kvetan V.<span style="mso-spacerun: yes;">&nbsp; </span>Barriers to Ultrasonography Training in Critical Care Medicine Fellowships: A Survey of Program Directors.<span style="mso-spacerun: yes;">&nbsp; </span><span style="mso-bidi-font-style: italic;">Crit Care Med. 2010 Oct;38(10):1978-83.</span></span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">, LeFrancois D and Eisen LA.<span style="mso-spacerun: yes;">&nbsp; </span>Polypharmacy in the Elderly: Metformin-Associated Lactic Acidosis Precipitated by Acute Renal Failure Induced by Zoledronic Acid.<span style="mso-spacerun: yes;">&nbsp; </span><span style="mso-bidi-font-style: italic;">Clinical Geriatrics</span>&nbsp;2011:19(2):50-52</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">.<span style="mso-spacerun: yes;">&nbsp; </span>Is it Right to Measure the Productivity of Senior Clinician/Educators by Relative Value Units (RVUs)?<span style="mso-spacerun: yes;">&nbsp; </span>J Grad Med Educ. 2011 March; 3(1): 9</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">, Pokharel R and Gong MN.<span style="mso-spacerun: yes;">&nbsp; </span>Statins and Outcomes in Patients with Bloodstream Infection: A Propensity-Score Analysis.<span style="mso-spacerun: yes;">&nbsp; </span>Crit Care Med. 2012 Apr;40(4):1064-71 as <em><u>featured article</u></em></span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">LeFrancois D and <strong style="mso-bidi-font-weight: normal;">Leung S</strong>.<span style="mso-spacerun: yes;">&nbsp; </span>Advancing into the Community.<span style="mso-spacerun: yes;">&nbsp; </span>Am J Med. 2012 Jul;125(7):657-6</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Yu S, <strong style="mso-bidi-font-weight: normal;">Leung S</strong>, Heo M, Soto GJ, Shah RT Gunda S and Gong MN.<span style="mso-spacerun: yes;">&nbsp; </span>Comparison of Risk Prediction Scoring Systems for Non-ICU Hospitalized Patients.<span style="mso-spacerun: yes;">&nbsp; </span></span><a title="Critical care (London, England)." href="http://www.ncbi.nlm.nih.gov/pubmed/24970344"><span style="background: white; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"><span style="color: #0000ff;">Crit Care.</span></span></a><span style="background: white; color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext;">&nbsp;</span><span style="background: white; color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext;">2014 Jun 26;18(3):R132. </span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-fareast-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-fareast-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">, Gregg SR, Coopersmith CM, Layon AJ, Oropello J, Brown DR, Pastores SM, Kvetan V. <span style="mso-bidi-font-weight: bold;">Critical Care Organizations: Business of Critical Care and Value/Performance Building. </span></span><a title="Critical care medicine." href="https://www.ncbi.nlm.nih.gov/pubmed/28863012"><span style="color: #0000ff;"><span style="background: white; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Crit</span></span><span style="background: white; color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; text-decoration: none; text-underline: none; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext;">&nbsp;</span><span style="background: white; color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; text-decoration: none; text-underline: none; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext;">Care</span><span style="background: white; color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; text-decoration: none; text-underline: none; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext;">&nbsp;</span><span style="background: white; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"><span style="color: #0000ff;">Med.</span></span></a><span style="background: white; color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext;">&nbsp;</span><span style="background: white; color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext;">2018 Jan;46(1):1-11 </span><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">as <em><u>featured article</u></em></span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Jorde UP, Shah AM, Sims DB, Madan S, Siddiqi N, Luke A, Saeed O, Patel SR, Murthy S, Shin J, Oveido J, Watts S, Jakobleff W, Forest S, Vukelic S, Belov D, Puius Y, Minamoto G, Muggia V, Carlese A, <strong style="mso-bidi-font-weight: normal;">Leung S</strong>, Rahmanian M, Leff J and Goldstein D.<span style="mso-spacerun: yes;">&nbsp; </span>Continuous-Flow Left Ventricular Assist Device Survival Improves with Multidisciplinary Approach.<span style="mso-spacerun: yes;">&nbsp; </span></span><a title="The Annals of thoracic surgery." href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Continuous-Flow+Left+Ventricu… style="background: white; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;"><span style="color: #0000ff;">Ann Thorac Surg.</span></span></a><span style="background: white; color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext;">&nbsp;2019 Aug;108(2): 508-516</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-list: l0 level1 lfo1;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Sadikot C, <strong style="mso-bidi-font-weight: normal;">Leung S</strong>, Vassilakis A and LeFrancois D. <span style="color: #212121;">Addressing Resident Retention of Musculoskeletal Skills, Knowledge, and Confidence: a Randomized Controlled Study of a Clinic Intervention.<span style="mso-spacerun: yes;">&nbsp; </span>J Gen Intern Med. 2021 Jan 26.<span style="mso-spacerun: yes;">&nbsp; </span>Online ahead of print.</span></span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; ; mso-list: l0 level1 lfo1; mso-layout-grid-align: none;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">, Pastores SM, Oropello JM, Lilly CM, Galvagno SM, Badjatia N, Jacobi J, Herr DL and Oliveira JD.<span style="mso-spacerun: yes;">&nbsp; </span><span style="mso-bidi-font-weight: bold;">Regionalization of Critical Care in the United States: Current State and Proposed Framework</span>.<span style="mso-spacerun: yes;">&nbsp; </span>Manuscript was accepted in <em style="mso-bidi-font-style: normal;">Critical Care Medicine </em>on April 16^th, 2021.</span></p>
</li>
</ol>
<p>&nbsp;</p>
<p style="margin: 0in;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">B.<span style="mso-spacerun: yes;">&nbsp; </span>Books, Chapters in Books, and Review Articles:</span></strong></p>
<p>&nbsp;</p>
<ol style="list-style-type: decimal; direction: ltr;">
<li style="color: #000000; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">.<span style="mso-spacerun: yes;">&nbsp; </span>Surgical Site Infections. 5-minute Critical Care Consult 2011.</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-add-space: auto; mso-list: l0 level1 lfo1;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Shiloh AL, Savel RH, <strong style="mso-bidi-font-weight: normal;">Leung S</strong>, Carlese A and Kvetan V.<span style="mso-spacerun: yes;">&nbsp; </span>Mass Critical Care.<span style="mso-spacerun: yes;">&nbsp; </span>Textbook of Critical Care, 6^th Edition, 2011</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0pt; mso-add-space: auto; mso-list: l0 level1 lfo1;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Leung S</span></strong><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">.<span style="mso-spacerun: yes;">&nbsp; </span>Controversies: Can Intensivist Performance Be Measured? Critical Care Medicine, McGraw-Hill, 2016</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0pt; mso-add-space: auto; mso-list: l0 level1 lfo1;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Carlese A and <strong style="mso-bidi-font-weight: normal;">Leung S</strong>.<span style="mso-spacerun: yes;">&nbsp; </span>Extracorporeal Membrane Oxygenation (ECMO). Critical Care Medicine, McGraw-Hill, 2016</span></p>
</li>
</ol>
<p>&nbsp;</p>
<p style="margin: 0in 0.25in 0in 0in; text-align: justify; text-indent: 0.25in;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Letters to the Editor:</span></strong></p>
<p>&nbsp;</p>
<ol style="list-style-type: decimal; direction: ltr;">
<li style="color: #000000; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-add-space: auto; mso-list: l1 level1 lfo2;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">LeFrancois D and <strong style="mso-bidi-font-weight: normal;">Leung S</strong>.<span style="mso-spacerun: yes;">&nbsp; </span>Letter to the Editor: Opioids and Clostridium Difficile Infection.<span style="mso-spacerun: yes;">&nbsp; </span>Am J Med. 2013 Apr;126(4): e15</span></p>
</li>
<li style="color: #000000; font-family: 'Calibri',sans-serif; font-size: 12pt; font-style: normal; font-weight: normal;">
<p style="color: #000000; font-family: 'Times New Roman',serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 0in; margin-bottom: 0in; mso-add-space: auto; mso-list: l1 level1 lfo2;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">LeFrancois D and<strong style="mso-bidi-font-weight: normal;"> Leung S</strong>.<strong style="mso-bidi-font-weight: normal;"><span style="mso-spacerun: yes;">&nbsp; </span></strong>Letter to the Editor: Bedside Rounding Strategies Used by Bedside Teachers. <span style="mso-bidi-font-weight: bold;">J Gen Intern Med</span>. 2013, Sep; 28(9):1130.</span></p>
</li>
</ol>
<p>&nbsp;</p>
<p style="margin: 0in;"><strong><span style="color: black; font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">C.<span style="mso-spacerun: yes;">&nbsp;&nbsp; </span>Community Education: Patient advice</span></strong></p>
<p>&nbsp;</p>
<p style="margin: 0in 0in 0in 0.25in; mso-add-space: auto;"><span style="font-family: 'Calibri',sans-serif; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin;">Kaplan R and <strong style="mso-bidi-font-weight: normal;">Leung S</strong>. <span style="background: white; color: black; mso-bidi-font-weight: bold; mso-color-alt: windowtext;">Surviving Critical Illness</span>: What Is Post-ICU Syndrome (PICS) And How Does It Affect Patients and Families?<span style="mso-spacerun: yes;">&nbsp; </span><span style="color: black; mso-bidi-font-weight: bold;">U.S News and World Report patient advice blog on July 25^th, 2017</span></span></p>
<p>&nbsp;</p>

EMR ID

4737

Is Open Scheduling

Off